X. Yataganas

发表

B. Clarkson, X. Yataganas, A. Strife, 1976, Medical and pediatric oncology.

FLOW MICROFLUOROMETRIC ANALYSIS OF CELL KILLING WITH CYTOTOXIC DRUGS

B. Clarkson, X. Yataganas, 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Hypereosinophilia associated with monosomy 7.

K. Stamatopoulos, G. Paterakis, D. Loukopoulos, 1995, Cancer genetics and cytogenetics.

Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.

S. Akel, D. Loukopoulos, X. Yataganas, 2002, Clinical and laboratory haematology.

Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients.

S. Akel, D. Loukopoulos, X. Yataganas, 2000, Cancer genetics and cytogenetics.

Flow-cytometric detection of minimal residual disease with atypical antigen combinations in patients with de novo acute myeloid leukemia

X. Yataganas, E. Plata, H. Choremi-Papadopoulou, 2000, Annals of Hematology.

Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients

Nikolaos Laoutaris, E. Terpos, X. Yataganas, 2002, British journal of haematology.

Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology

N. Giannakoulas, I. Kotsianidis, X. Yataganas, 2006, Annals of Hematology.

Clonal Analysis of Granulocyte-Monocyte Colony-Forming Unit Cells with the Human Androgen Receptor Gene in Chronic Myeloid Leukemia

S. Akel, D. Loukopoulos, X. Yataganas, 2003, International journal of hematology.

Tartrate‐resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myeloma

J. Goldman, E. Hatjiharissi, E. Terpos, 2003, International journal of cancer.

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma

E. Terpos, X. Yataganas, K. Anargyrou, 2000, European journal of haematology.

Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin‐6 and β2‐microglobulin in multiple myeloma

J. Goldman, E. Terpos, X. Yataganas, 2003, European journal of haematology.

Endemic goitre in Greece: a study of 379 twin pairs.

D. Koutras, X. Yataganas, B. Malamos, 1967, Journal of medical genetics.

Angio‐immunoblastic lymphadenopathy terminating as Hodgkin's disease

C. Papadimitriou, G. Pangalis, X. Yataganas, 1977, Cancer.

A novel chromosomal abnormality involving chromosomes 2 and 18 in a patient with myelodysplastic syndrome.

K. Stamatopoulos, D. Loukopoulos, X. Yataganas, 1997, Cancer genetics and cytogenetics.

Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment

E. Terpos, X. Yataganas, G. Vaiopoulos, 2001, Calcified Tissue International.

Quantification of α‐Chain Excess in Erythrocytes in β‐Thalassaemia by Microinterferometry *

G. Gahrton, X. Yataganas, P. Fessas, 1972, British journal of haematology.

THE PATTERN OF HEMOGLOBIN PRECIPITATION IN THALASSEMIA AND ITS SIGNIFICANCE *

X. Yataganas, P. Fessas, 1969, Annals of the New York Academy of Sciences.

Quantitative cytochemistry of glycogen in blood cells. Methods and clinical application.

G. Gahrton, X. Yataganas, 1976, Progress in histochemistry and cytochemistry.

Proposal for a novel prognostic index ( RANKL ) / osteoprotegerin ( OPG ) ratio predicts survival in multiple

J. Goldman, E. Hatjiharissi, E. Terpos, 2003 .

Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response

S. Akel, E. Terpos, D. Loukopoulos, 2002, Annals of Hematology.

Danazol Therapy for Thrombocytopenia in Patients with Myelodysplastic Syndromes

E. Terpos, D. Loukopoulos, X. Yataganas, 2002, Acta Haematologica.

Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders.

D. Mavrogianni, E. Terpos, D. Loukopoulos, 2001, Haematologia.

Cytogenetic analysis and RAS mutations in primary myelodysplastic syndromes.

C. Kittas, X. Yataganas, G. Vaiopoulos, 1999, Cancer genetics and cytogenetics.

Acute promyelocytic leukemia relapsing into FAB-M2 acute myeloid leukemia with trisomy 8.

X. Yataganas, C. Pangalos, N. Stavroyianni, 2000, Cancer genetics and cytogenetics.

Beta-glucuronidase activity of lymph node imprints from malignant lymphomas and chronic lymphocytic leukaemia.

G. Pangalis, X. Yataganas, P. Fessas, 1977, Journal of clinical pathology.

Autoimmune hemolytic anemia during α-interferon treatment in a patient with chronic myelogenous leukemia

K. Stamatopoulos, X. Yataganas, G. Vaiopoulos, 2001 .

Early changes induced in rat liver by methylazoxymethanol acetate: mitotic abnormalities and polyploidy.

S. Sternberg, X. Yataganas, M. S. Zedeck, 1974, Journal of the National Cancer Institute.

Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients

D. Mavrogianni, E. Terpos, D. Loukopoulos, 2002, International journal of hematology.

alpha Interferon treatment of essential thrombocythaemia and other myeloproliferative disorders with excessive thrombocytosis.

V. Boussiotis, X. Yataganas, E. Plata, 1991, European journal of cancer.

Proliferative kinetics of central nervous system (CNS) leukemia

J. Fried, B. Clarkson, X. Yataganas, 1975, Cancer.

Third International Congress of Histochemistry and Cytochemistry: August 18–22, 1968, New York, N.Y.

W. D. Selles, W. W. Doane, J. E. Kephart, 1968 .

Third International Congress of Histochemistry and Cytochemistry

Richard E. Cornell, W. D. Selles, W. W. Doane, 1968 .

Dietary sources of iodine in areas with and without iodine-deficiency goiter.

D. Koutras, X. Yataganas, B. Malamos, 1970, The American journal of clinical nutrition.

Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.

X. Yataganas, G. Vayopoulos, J. Meletis, 1991, Chemotherapy.

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index.

J. Goldman, E. Hatjiharissi, E. Terpos, 2003, Blood.

Proliferative Activity and Glycogen Accumulation of Erythroblasts in β‐Thalassaemia

G. Gahrton, B. Thorell, X. Yataganas, 1973, British journal of haematology.

Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations.

J. Fried, B. Clarkson, X. Yataganas, 1976, Computers and biomedical research, an international journal.

Tropical pyomyositis in a Greek adult.

X. Yataganas, K. Konstantopoulos, G. Vayopoulos, 1989, Scandinavian journal of infectious diseases.

DNA, RNA and hemoglobin during erythroblast maturation. A cytophotometric study.

G. Gahrton, B. Thorell, X. Yataganas, 1970, Experimental cell research.

Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine.

B. Clarkson, X. Yataganas, A. Strife, 1974, Cancer research.

Quantitation of hemoglobin in single erythrocytes with and without fetal hemoglobin

X. Yataganas, G. Vaiopoulos, P. Fessas, 1987, European journal of haematology.

The Hemoglobin Content and Concentration of Single Fetal Erythrocytes Obtained by Placentocentesis from Mothers with Heterozygous β‐Thalassemia a

D. Loukopoulos, X. Yataganas, P. Fessas, 1985, Annals of the New York Academy of Sciences.

ULTRASTRUCTURE OF THE INCLUSION BODIES AND NUCLEAR ABNORMALITIES IN β‐THALASSEMIC ERYTHROBLASTS *

X. Yataganas, A. Polliack, E. Rachmilewitz, 1974, Annals of the New York Academy of Sciences.

Intranuclear hemoglobin in erythroblasts of β-thalassemia.

G. Gahrton, B. Thorell, X. Yataganas, 1974 .

'Fetal' erythropoiesis following bone marrow transplantation as estimated by the number of F cells in the peripheral blood.

X. Yataganas, G. Eliopoulos, K. Konstantopoulos, 1994, Bone marrow transplantation.

Reverse transcription polymerase chain reaction for the diagnosis and molecular monitoring of the PML/RARα fusion gene in acute promyelocytic leukemia

K. Stamatopoulos, G. Pangalis, X. Yataganas, 1995 .

Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire

K. Stamatopoulos, K. Zoi, P. Kollia, 2000, Leukemia.

Somatic hypermutation of immunoglobulin variable region genes: focus on follicular lymphoma and multiple myeloma

K. Stamatopoulos, D. Loukopoulos, X. Yataganas, 1998, Immunological reviews.

Analysis of the κ light chain variable region in multiple myeloma

G. Paterakis, D. Loukopoulos, P. Kollia, 1996 .

Molecular analysis of immunoglobulin genes in multiple myeloma.

K. Stamatopoulos, X. Yataganas, C. Kosmas, 1999, Leukemia & lymphoma.

Comparison of allogeneic stem cell transplantation, high‐dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

A. Tsimberidou, X. Yataganas, M. Papaioannou, 2003, Cancer.

An Electron Microscopic Study of the Nuclear Abnormalities in Erythroblasts in Beta‐Thalassaemia Major

B. Thorell, X. Yataganas, A. Polliack, 1974, British journal of haematology.

Correction of anaemia and thrombocytopenia in a case of adult Type I osteopetrosis with recombinant human erythropoietin (rHuEPO)

D. Loukopoulos, X. Yataganas, G. Vaiopoulos, 1995, British journal of haematology.

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study

K. Stamatopoulos, P. Korkolopoulou, E. Patsouris, 2003, Leukemia.

Prognostic evaluation of the microvascular network in myelodysplastic syndromes

P. Korkolopoulou, E. Patsouris, E. Patsouris, 2001, Leukemia.

Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature

K. Stamatopoulos, E. Terpos, X. Yataganas, 2001, Leukemia.

Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia

K. Stamatopoulos, K. Zoi, G. Paterakis, 2001, British journal of haematology.

Malignancy: Molecular Demonstration of BCR/ABL Fusion in a Patient with Chronic Myelogenous Leukemia with Basophilia Carrying a Variant t(16;22) (q24;q11) Philadelphia Chromosome.

D. Loukopoulos, X. Yataganas, C. Pangalos, 1999, Hematology.

Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.

A. Tsimberidou, G. Paterakis, X. Yataganas, 2002, Leukemia research.

Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system.

E. Terpos, D. Loukopoulos, X. Yataganas, 1997, Leukemia & lymphoma.

Expression of recombination activating genes-1 and-2 immunoglobulin heavy chain gene rearrangements in acute myeloid leukemia: evaluation of biological and clinical significance in a series of 76 uniformly treated patients and review of the literature.

K. Stamatopoulos, G. Paterakis, X. Yataganas, 2003, Haematologica.

FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study.

D. Mavrogianni, X. Yataganas, E. Plata, 2006, Anticancer research.

The effect of recombinant α-interferon on natural killer cell activity and clinical course in patients with myelodysplastic syndrome

X. Yataganas, E. Plata, G. Eliopoulos, 1991, Annals of Hematology.

Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.

D. Loukopoulos, X. Yataganas, N. Viniou, 1995, Leukemia & lymphoma.

Simultaneous PML/RARα and AML 1/ETO gene rearrangements in a patient with acute myeloid leukemia

X. Yataganas, N. Stavroyianni, T. Kalmantis, 1999, Leukemia.

Absence of Somatic Hypermutation in the Open Reading Frame of the Bcl-2 Gene Participating in the t(14;18) Chromosomal Translocation in Follicular Lymphoma

K. Stamatopoulos, X. Yataganas, C. Kosmas, 2002, Leukemia & lymphoma.

Endemic goiter in Greece: an iodine balance study in the field.

D. Koutras, X. Yataganas, B. Malamos, 1967, The Journal of clinical endocrinology and metabolism.

Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique.

F. Traganos, B. Clarkson, X. Yataganas, 1975, Acta cytologica.

Trisomy 11 with loss of the Y chromosome and trisomy 13 in a case of de novo acute myeloid leukemia.

D. Loukopoulos, X. Yataganas, E. Plata, 1996, Cancer genetics and cytogenetics.

Development of plasma cell tumors during treatment of multiple myeloma

D. Loukopoulos, X. Yataganas, G. Vaiopoulos, 1996, Annals of Hematology.

Carcinomatous monoarthritis

P. Kaklamanis, X. Yataganas, P. Fessas, 2007, Clinical Rheumatology.

Trisomy 8 in a patient who responded to therapy with all‐trans‐retinoic acid and developed paroxysmal nocturnal haemoglobinuria

D. Loukopoulos, X. Yataganas, G. Vaiopoulos, 1997, British journal of haematology.

3-glucuronidase activity of lymph node imprints from malignant lymphomas and chronic lymphocytic leukaemia

X. Yataganas, P. Fessas, G. Pangalis, 2004 .

Veto Players and Decision-Making in the EU after Nice

George Tsebelis, George Tsebelis, X. Yataganas, 2002 .

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index.

J. Goldman, E. Hatjiharissi, E. Terpos, 2003, Blood.